Aandelen in “Fabricage van farmaceutische preparaten”

Aandeel Datum Koers Evolutie
vlag Fagron 26/06 23,800 EUR
-0,63% 		-0,63%
vlag Forte Biosciences Inc 26/06 21,030 USD
+12,40% 		+12,40%
vlag Fortress Biotech Inc 26/06 20,050 USD
-0,64% 		-0,64%
vlag Fortress Biotech Inc 26/06 2,760 USD
-8,61% 		-8,61%

Nieuws over “Fabricage van farmaceutische preparaten”

26/06 · SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease · Persbericht

26/06 · SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease · Persbericht

26/06 · Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

26/06 · Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

26/06 · Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis · Persbericht

26/06 · Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference · Persbericht

26/06 · AbbVie to Host Second-Quarter 2026 Earnings Conference Call · Persbericht

26/06 · Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy · Persbericht

25/06 · uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares · Persbericht

25/06 · Are NUVL, CPRX, TMHC Obtaining Fair Deals for their Shareholders? · Persbericht

25/06 · Zoetis Inc. (ZTS) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP · Persbericht

25/06 · Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet · Persbericht

25/06 · Abbott hosts conference call for second-quarter earnings · Persbericht

25/06 · Prestige Consumer Healthcare Inc. (PBH) Clear Eyes® and Pillar5 Problems Drive Stock Lower, HBSS Investigating · Persbericht

25/06 · Duitse farmareus Merck sluit Amerikaanse biotechdeal van 10 miljard euro · Tijd.be (€)

De Duitse farmagroep Merck neemt de Amerikaanse biotechleverancier Bio-Techne over voor 9,9 miljard euro. Het versterkt zo zijn positie in farma- en biotechdienstverlening.

25/06 · Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial · Persbericht

25/06 · What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management · Persbericht

25/06 · Press Release: Sanofi Foundation opens new chapter centered on future generations · Persbericht

25/06 · Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update · Persbericht

24/06 · Lost Money on Zoetis Inc. (ZTS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky · Persbericht

24/06 · Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders · Persbericht

Mijn selecties